1. Were we ever cutting edge? JNJ is too risk averse.
2. We go with proven technology. Our vaccine approach is based on a platform used to support many other commercialized vaccines.
1. Were we ever cutting edge? JNJ is too risk averse.
2. We go with proven technology. Our vaccine approach is based on a platform used to support many other commercialized vaccines.